STC
HAE icon

SEI Trust Company’s Haemonetics HAE Stock Holding History

SEI Trust Company’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$3.04M Buy
86,987
+4,987
+6% +$178K 0.03% 531
2014
Q2 		$2.89M Buy
82,000
+81,800
+40,900% +$2.73M 0.03% 553
2014
Q1 		$7K Buy
+200
New +$7.64K ﹤0.01% 1602

Other funds holding HAE

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

SEI Trust Company's HAE Position: Q3 2014 in Review

SEI Trust Company increased its Haemonetics (HAE) stake by 6.1% in Q3 2014, buying an estimated $178K and bringing the position to 86,987 shares worth $3.04M. The position accounts for 0.03% of the portfolio, ranked #531.

SEI Trust Company first reported a position in HAE in Q1 2014 and has held it in 3 quarters since. 171 funds tracked by Wall St. Rank hold HAE as of Q3 2014.

  • SEI Trust Company held 86,987 shares of Haemonetics worth $3.04M as of Q3 2014.
  • SEI Trust Company bought 4,987 Haemonetics shares in Q3 2014, an estimated $178K.
  • Haemonetics made up 0.03% of SEI Trust Company's portfolio in Q3 2014, its #531 holding.
  • SEI Trust Company first reported a position in Haemonetics in Q1 2014 and has held it in 3 quarters since.
  • 171 funds tracked by Wall St. Rank held Haemonetics as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.